Genomic Approaches to Hypertension. Cardiol Clin 2017 May;35(2):185-196
Date
04/17/2017Pubmed ID
28411893DOI
10.1016/j.ccl.2016.12.001Scopus ID
2-s2.0-85017435059 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
Genomic insights and analyses of Mendelian hypertension (HTN) syndromes and Genome-Wide Association study (GWAS) on essential hypertension have contributed to the depth of understanding of the genetics origins of hypertension. Mendelian syndromes are important for the field, since such knowledge leads to specific insights about disease pathogenesis and the potential for precision medicine. The clinical impact of findings of on essential hypertension is continuously evolving, and the insights accrued will refine efforts to combat the societal impact of hypertension. Comprehensive identification of all genomic variants of hypertension, along with their individual associated mechanisms, is paving the way forward in the era of personalized medicine. The overriding challenge for care providers is to reduce health inequities through improved compliance and, perhaps, new paradigms for implementation science that incorporate genomic medicine.
Author List
Dodoo SN, Benjamin IJAuthor
Ivor J. Benjamin MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Genome-Wide Association StudyGenomics
Humans
Hypertension
